iiinova — where your digital self keeps evolving

Reposted by Alex Rampotas

VJHemOnc @vjhemonc.bsky.social · 29/01/2026

Have you registered for #CART26 yet?🩸 Hear from @alexrampotas.bsky.social, who highlights the importance of the meeting as a platform for exchanging ideas & showcasing new data in the field of CAR-T & cellular therapy: 🎥 buff.ly/WhO2pQl Register here: 👉 buff.ly/NBpWzCH @theebmt.bsky.social

022

Reposted by Alex Rampotas

Beth Psaila @bethpsaila.bsky.social · 15/06/2025

Exciting times for mutCALR MPNs - lovely data from the ET cohort presented in late breaking abstract at @EHA_Hematology. Rapid platelet control after just 2 doses with 89% of patients benefitting from a molecular response with INCA033989. @mpnvoice.bsky.social @mpnrf.bsky.social @mpnhv.bsky.social

0114

Alex Rampotas @alexrampotas.bsky.social · 02/06/2025

Check our commentary on the amazing work by Falgas et all on developing a TIM-3 armored CAR-T therapy

010

Alex Rampotas @alexrampotas.bsky.social · 04/04/2025

🚨Very excited to see our work with Prof Claire Roddie out in @bloodjournal.bsky.social CAR-T has revolutionized treatment for B-ALL, but what’s next? We discuss innovations, challenges, and the road ahead. 🔗 ashpublications.org/blood/articl... #Leukemia #CARTcell #Hematology

020

Reposted by Alex Rampotas

Beth Psaila @bethpsaila.bsky.social · 27/03/2025

We are recruiting!! Ads now live for a Data Coordinator and 2 Research Assistants/biobankers to join a new @ludwigcancer.bsky.social - @imm.ox.ac.uk joint initiative to prevent progression from early- to advanced blood cancer. Joint posts with Adam Mead+others in Oxford Ludwig. Links below

11611

Alex Rampotas @alexrampotas.bsky.social · 29/01/2025

Fantastic news and very well deserved award!!! It has been amazing working together

030

Alex Rampotas @alexrampotas.bsky.social · 21/12/2024

Bye bye, bispecific? Check out our commentary on the development of a CD19/BCMA dual targeting CAR-T for non-Hodgkin Lymphoma led by Bachiller et al. Co-transduction for the win! Link below ⬇️ for free access authors.elsevier.com/a/1kIWB5QliS...

020

Alex Rampotas @alexrampotas.bsky.social · 19/12/2024

Many thanks for highlighting our work on CAR-T for Myelofibrosis! It has been a great meeting in San Diego #ASH24 ashpublications.org/ashnewsdaily...

ashpublications.org

Flash Forward: Blood Cancer Highlights and Insights From ASH 2024 | ASH News Daily | American Society of Hematology

000

Reposted by Alex Rampotas

Camelia Benlabiod @cameliabenlabiod.bsky.social · 10/12/2024

As we’re coming towards the end of #ASH2024 I’d like to express my gratitude for the great science, company and feedback! @antoniorromera.bsky.social @alexrampotas.bsky.social @bethpsaila.bsky.social

1102

Alex Rampotas @alexrampotas.bsky.social · 10/12/2024

It was great pleasure. Amazing meeting with great MPN research presented

010

Alex Rampotas @alexrampotas.bsky.social · 09/12/2024

Amazing presentation by Camelia Benlabiod (@beth_psaila / Caroline Marty lab) on the biology of calreticulin driven myelofibrosis in an immunocompetent mouse model #ASH24 #MPNsm

131

Alex Rampotas @alexrampotas.bsky.social · 09/12/2024

Looking forward to presenting our result and discussing all about CAR-T cell therapy for mutated calreticulin myelofibrosis #ASH24 Do join!

031

Reposted by Alex Rampotas

American Society of Hematology @ash.hematology.org · 09/12/2024

You have been telling us why you chose #hematology and what inspires you each day. Your answers are becoming art!🎨 See it live in the Hall A lobby. #ASH24 #Hemesky

0163

Alex Rampotas @alexrampotas.bsky.social · 08/12/2024

Very eloquent presentation by Antonio Romera from @bethpsaila.bsky.social lab on megakaryocyte biology and ability to take on DNA damage! Fantastic work #ASH24

1112

Alex Rampotas @alexrampotas.bsky.social · 08/12/2024

Very honoured to receive the ASH-BSH abstract achievement award The result of the tremendous work by so many talented people who I had the privilege to work with Zoe Wong, Isaac Gannon, @bethpsaila.bsky.social, Claire Roddie, Martin Pule and many more #ASH24

4100

Alex Rampotas @alexrampotas.bsky.social · 08/12/2024

Very pleased to present the results of a UK wide collaborative study on real world efficacy and safety of Momelotininb - >60% anaemia responses at 6 months -G1-2 peripheral neuropathy (15%) -unexpected thrombocytosis (?hepcidin dysregulation due to AVCR1 inhibition) #ASH24 @bethpsaila.bsky.social

042

Reposted by Alex Rampotas

Beth Psaila @bethpsaila.bsky.social · 07/12/2024

Sunrise and moonset beyond the Coronado Bridge on a beautiful run around San Diego bay this morning

2122

Alex Rampotas @alexrampotas.bsky.social · 07/12/2024

Attending #ASH24 and missing my baby boy. At least I can get him on my cup of coffee

030

Alex Rampotas @alexrampotas.bsky.social · 06/12/2024

Off to #ASH24. Books/music/movies all ready for 12h of economy flight 💪

020

Reposted by Alex Rampotas

Susie Shapiro @susie-shapiro.bsky.social · 04/12/2024

Really proud of our physio Steph! Thank you to UK Haemophilia Society, Ben and others for this lovely recognition of her care and support! @ouhospitals.bsky.social www.ouh.nhs.uk/news/article...

ouh.nhs.uk

Award-winning physiotherapist celebrated for ‘outstanding’ care - Oxford University Hospitals

Award-winning physiotherapist celebrated for ‘outstanding’ care

021

Alex Rampotas @alexrampotas.bsky.social · 02/12/2024

Very nice review. As we have more options for myelofibrosis the choice of the right JAKi at the right time becomes ever more important

030

Reposted by Alex Rampotas

Beth Psaila @bethpsaila.bsky.social · 29/11/2024

Do swing by to hear: (1) @antoniorromera.bsky.social present his fascinating work on how megakaryocytes tolerate whole genome duplication, implications for genome integrity & cancer evolution

153

Reposted by Alex Rampotas

Beth Psaila @bethpsaila.bsky.social · 29/11/2024

and also not to be missed - Ros Cooper and Dan Royston's oral abstract 'mapping the human bone marrow in MPNs using Spatial Transcriptomics'

053

Reposted by Alex Rampotas

Beth Psaila @bethpsaila.bsky.social · 29/11/2024

(3) Camelia Benlabiod presents her work from her PhD with Caroline Marty & Isabelle Plo @ Gustave Roussy on dissecting the cell-of-origin of mutCALR driven MPNs, and how del52 and ins5 elicit different signalling responses

253

Reposted by Alex Rampotas

Beth Psaila @bethpsaila.bsky.social · 29/11/2024

(2) @alexrampotas.bsky.social from Pule/Roddie Labs @uclofficial.bsky.social presenting joint work (co-led by Zoe Wong from my group)-1st-in-class CAR-T against mutCALR MPNs & evaluation in the relevant human tissue environment using @abattacks.bsky.social bone marrow organoids model

173

Reposted by Alex Rampotas

Beth Psaila @bethpsaila.bsky.social · 29/11/2024

Finally - thanks to a collaborative effort from the NCRI MPN subgroup across the UK - we are super excited to share a poster presenting 'real-world' efficacy and safety data of momelotinib for patients with myelofibrosis and anaemia

153

Reposted by Alex Rampotas

Beth Psaila @bethpsaila.bsky.social · 29/11/2024

Excited for #ASH24 & thrilled that *3* brilliant folks from the team have oral presentations, travel awards and 2/3 nominated for **best of ASH**!! @imm.ox.ac.uk @ox.ac.uk @cancerresearchuk.org @ludwigcancer.bsky.social

3337

Reposted by Alex Rampotas

American Society of Hematology @ash.hematology.org · 21/11/2024

Hello, #hematology community! ASH is now on BlueSky. We're here to share cutting-edge research and educational resources and connect global experts in blood diseases. Join us in advancing hematology together. Welcome, colleagues! #BloodSky #HemeSky #MedSky

38817